BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 9834220)

  • 1. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.
    Gabrilovich D; Ishida T; Oyama T; Ran S; Kravtsov V; Nadaf S; Carbone DP
    Blood; 1998 Dec; 92(11):4150-66. PubMed ID: 9834220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.
    Ohm JE; Shurin MR; Esche C; Lotze MT; Carbone DP; Gabrilovich DI
    J Immunol; 1999 Sep; 163(6):3260-8. PubMed ID: 10477595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
    Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
    Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells.
    Oyama T; Ran S; Ishida T; Nadaf S; Kerr L; Carbone DP; Gabrilovich DI
    J Immunol; 1998 Feb; 160(3):1224-32. PubMed ID: 9570538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H1(0) histone and differentiation of dendritic cells. A molecular target for tumor-derived factors.
    Gabrilovich DI; Cheng P; Fan Y; Yu B; Nikitina E; Sirotkin A; Shurin M; Oyama T; Adachi Y; Nadaf S; Carbone DP; Skoultchi AI
    J Leukoc Biol; 2002 Aug; 72(2):285-96. PubMed ID: 12149419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
    Dikov MM; Ohm JE; Ray N; Tchekneva EE; Burlison J; Moghanaki D; Nadaf S; Carbone DP
    J Immunol; 2005 Jan; 174(1):215-22. PubMed ID: 15611243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF as a mediator of tumor-associated immunodeficiency.
    Ohm JE; Carbone DP
    Immunol Res; 2001; 23(2-3):263-72. PubMed ID: 11444391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.
    Gabrilovich DI; Chen HL; Girgis KR; Cunningham HT; Meny GM; Nadaf S; Kavanaugh D; Carbone DP
    Nat Med; 1996 Oct; 2(10):1096-103. PubMed ID: 8837607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells.
    Huang XL; Takakura N; Suda T
    Biochem Biophys Res Commun; 1999 Oct; 264(1):133-8. PubMed ID: 10527853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer and B-lymphoid potential in CD34+ cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor.
    Nakayama N; Fang I; Elliott G
    Blood; 1998 Apr; 91(7):2283-95. PubMed ID: 9516126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients.
    Young PP; Hofling AA; Sands MS
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11951-6. PubMed ID: 12195016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment.
    Bautz F; Rafii S; Kanz L; Möhle R
    Exp Hematol; 2000 Jun; 28(6):700-6. PubMed ID: 10880756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor.
    Casella I; Feccia T; Chelucci C; Samoggia P; Castelli G; Guerriero R; Parolini I; Petrucci E; Pelosi E; Morsilli O; Gabbianelli M; Testa U; Peschle C
    Blood; 2003 Feb; 101(4):1316-23. PubMed ID: 12406876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor synergistically enhances bone morphogenetic protein-4-dependent lymphohematopoietic cell generation from embryonic stem cells in vitro.
    Nakayama N; Lee J; Chiu L
    Blood; 2000 Apr; 95(7):2275-83. PubMed ID: 10733496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation.
    Katoh O; Tauchi H; Kawaishi K; Kimura A; Satow Y
    Cancer Res; 1995 Dec; 55(23):5687-92. PubMed ID: 7585655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.
    Katoh O; Takahashi T; Oguri T; Kuramoto K; Mihara K; Kobayashi M; Hirata S; Watanabe H
    Cancer Res; 1998 Dec; 58(23):5565-9. PubMed ID: 9850095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells.
    Kuramoto K; Uesaka T; Kimura A; Kobayashi M; Watanabe H; Katoh O
    Cancer Res; 2000 Jan; 60(2):425-30. PubMed ID: 10667597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.
    Moore MA; Hattori K; Heissig B; Shieh JH; Dias S; Crystal RG; Rafii S
    Ann N Y Acad Sci; 2001 Jun; 938():36-45; discussion 45-7. PubMed ID: 11458524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways.
    Laxmanan S; Robertson SW; Wang E; Lau JS; Briscoe DM; Mukhopadhyay D
    Biochem Biophys Res Commun; 2005 Aug; 334(1):193-198. PubMed ID: 16002046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoattraction of CD34+ progenitor cells and dendritic cells to the site of tumor excision as the first step of an immunotherapeutic approach to target residual tumor cells.
    Banich JC; Kolesiak K; Young MR
    J Immunother; 2003; 26(1):31-40. PubMed ID: 12514427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.